Article
Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Minerva gastroenterologica e dietologica - 1 Dec 2006
Tharayil V S, Roberts L R
Abstract excerpt
Chronic hepatitis B virus (HBV) infection is the most frequent risk factor for development of hepatocellular carcinoma (HCC) worldwide. Studies of the molecular genetics and pathophysiology of HCC suggest that there are significant differences in the allelic imbalance, genome copy number, and gene expression patterns of HBV-induced HCC as compared to HCCs from other causes, which are presumably reflected to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
